BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 20042189)

  • 1. The genetics of statin-induced myopathy.
    Ghatak A; Faheem O; Thompson PD
    Atherosclerosis; 2010 Jun; 210(2):337-43. PubMed ID: 20042189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
    Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
    Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLCO1B1 variants and statin-induced myopathy.
    Vladutiu GD; Isackson PJ
    N Engl J Med; 2009 Jan; 360(3):304. PubMed ID: 19144951
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic myopathies.
    Mastaglia FL
    Curr Opin Neurol; 2010 Oct; 23(5):445-9. PubMed ID: 20581681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.
    Canestaro WJ; Austin MA; Thummel KE
    Genet Med; 2014 Nov; 16(11):810-9. PubMed ID: 24810685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interindividual differences in the response to statin therapy and gene polymorphisms related to myopathy during statin therapy].
    Dendramis G
    G Ital Cardiol (Rome); 2011 Mar; 12(3):182-5. PubMed ID: 21560474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and skeletal muscles toxicity: from clinical trials to everyday practice.
    Norata GD; Tibolla G; Catapano AL
    Pharmacol Res; 2014 Oct; 88():107-13. PubMed ID: 24835295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.
    Hou Q; Li S; Li L; Li Y; Sun X; Tian H
    Medicine (Baltimore); 2015 Sep; 94(37):e1268. PubMed ID: 26376374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.
    Neřoldová M; Stránecký V; Hodaňová K; Hartmannová H; Piherová L; Přistoupilová A; Mrázová L; Vrablík M; Adámková V; Hubáček JA; Jirsa M; Kmoch S
    Pharmacogenomics; 2016 Aug; 17(13):1405-14. PubMed ID: 27296017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins.
    Generaux GT; Bonomo FM; Johnson M; Doan KM
    Xenobiotica; 2011 Aug; 41(8):639-51. PubMed ID: 21425956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of vitamin D deficiency to statin myopathy.
    Gupta A; Thompson PD
    Atherosclerosis; 2011 Mar; 215(1):23-9. PubMed ID: 21185021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Researchers worry about myopathy risk for patients taking high-dose simvastatin.
    Mitka M
    JAMA; 2009 Jan; 301(3):261-2. PubMed ID: 19155447
    [No Abstract]   [Full Text] [Related]  

  • 17. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics and adverse drug reactions: the case of statins.
    Giorgi MA; Caroli C; Arazi HC; Di Girolamo G
    Expert Opin Pharmacother; 2011 Jul; 12(10):1499-509. PubMed ID: 21568825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic predisposition to atorvastatin-induced myopathy: a case report.
    Francesca Notarangelo M; Marziliano N; Antonietta Demola M; Pigazzani F; Guidorossi A; Angelica Merlini P; Ardissino D
    J Clin Pharm Ther; 2012 Oct; 37(5):604-6. PubMed ID: 22582980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study.
    Puccetti L; Ciani F; Auteri A
    Atherosclerosis; 2010 Jul; 211(1):28-9. PubMed ID: 20347093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.